GlassScriptPhysician profile
Alexander D Zider
NPI 1801197504
$7,086.96
in general payments reported to CMS, 2019-2025
37 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,330 · 2020: $352 · 2021: $342 · 2022: $422 · 2023: $633 · 2024: $3,342 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $2,606 · Food and Beverage: $2,035.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $2,606.35 |
| Food and Beverage | $2,035.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,939.35 | 2021-2024 | |
| Glaxosmithkline, LLC. | $924.88 | 2019-2025 | Trelegy Ellipta, Nucala, Arexvy |
| Astrazeneca Pharmaceuticals LP | $851.39 | 2019-2025 | Fasenra, Airsupra, Tezspire |
| Boehringer Ingelheim Pharmaceuticals, INC. | $508.22 | 2019-2025 | Ofev, Stiolto Respimat, Spiriva Respimat |
| Electromed, INC. | $243.83 | 2019-2021 | |
| Mylan Specialty L.P. | $177.02 | 2019-2023 | Yupelri |
| Genentech USA, INC. | $147.55 | 2019-2021 | |
| Pulmonx Corporation | $146.62 | 2019-2025 | Pulmonx Chartis Tablet Console, Zephyr Delivery Catheter, Zephyr Endobronchial Valve |
| Actelion Pharmaceuticals US, INC. | $137.08 | 2019-2024 | Opsumit, Uptravi |
| Insmed, INC. | $104.20 | 2019-2022 | |
| Genzyme Corporation | $84.97 | 2019-2024 | |
| Merck Sharp & Dohme LLC | $80.14 | 2024-2025 | Zerbaxa, Recarbrio |
| Grifols USA, LLC | $70.40 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $59.66 | 2019-2020 | |
| Baxter Healthcare | $47.92 | 2023-2025 | Hillrom - Vest System Model 105 Home Care, Hillrom - Life 2000 Ventilation System |
Show all 37 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Erbe USA INC | $47.00 | 2024-2025 | Cryo2 |
| Regeneron Healthcare Solutions, INC. | $46.71 | 2019-2025 | Dupixent |
| Jazz Pharmaceuticals INC. | $40.19 | 2019 | |
| Philips North America LLC | $36.17 | 2025 | Vest Therapy Und |
| Takeda Pharmaceuticals U.S.A., INC. | $27.98 | 2024 | Cuvitru |
| Novartis Pharmaceuticals Corporation | $27.47 | 2024 | |
| Advanced Respiratory, INC | $26.75 | 2019 | |
| Amgen INC. | $26.16 | 2024 | Tezspire |
| Lilly USA, LLC | $25.80 | 2025 | Zepbound |
| Inari Medical, INC. | $25.35 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Verona Pharma, INC. | $24.87 | 2025 | Ohtuvayre |
| Janssen Pharmaceuticals, INC | $24.22 | 2023 | Xarelto |
| Astellas Pharma US INC | $23.81 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $22.24 | 2019 | |
| Fisher & Paykel Healthcare INC | $21.75 | 2023 | Fisher & Paykel Healthcare |
| Portola Pharmaceuticals, LLC | $21.56 | 2019 | |
| Pfizer INC. | $20.65 | 2023 | |
| Chiesi USA, INC. | $20.01 | 2019 | |
| Gilead Sciences, INC. | $16.74 | 2019 | |
| Inogen, INC. | $13.51 | 2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Bayer Healthcare Pharmaceuticals INC. | $12.76 | 2019 | |
| Sanofi Pasteur INC. | $12.03 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexander Zider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.